TerminatedPhase 3NCT00451867
A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .
Studying Interstitial cystitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- John Kusek, PhD, CPSNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Intervention
- Mycophenolate Mofetil(drug)
- Enrollment
- 210 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007 – 2008
Study locations (11)
- Univeristy of California San Diego, San Diego, California, United States
- Stanford University Medical center, Stanford, California, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Maryland, Baltimore, Maryland, United States
- Henry Ford Hospital, Detroit, Michigan, United States
- William Beaumont Hospital, Royal Oak, Michigan, United States
- University of Rochester, Rochester, New York, United States
- University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
- University of Washington, Seattle, Washington, United States
- Queen's University, Kingston, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00451867 on ClinicalTrials.govOther trials for Interstitial cystitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06752603A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisOno Pharmaceutical Co. Ltd
- RECRUITINGEARLY PHASE1NCT04734106Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial CystitisWake Forest University Health Sciences
- RECRUITINGNANCT06366269Acupuncture First for IC/BPSUniversity Hospitals Cleveland Medical Center
- RECRUITINGPHASE2NCT06394830Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Vaneltix Pharma, Inc.
- RECRUITINGNCT06729151Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain SyndromeWalter Reed National Military Medical Center
- RECRUITINGNCT06719232Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationJahn Ferenc South Pest Teaching Hospital
- RECRUITINGPHASE2, PHASE3NCT06096597Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder SyndromeDavid Sheyn
- RECRUITINGNANCT06299683Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentVanderbilt University Medical Center